AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (December 8, 2006). doi:10.1152/ajpheart.00434.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/4/H1847    most recent
00434.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berman, M.
Right arrow Articles by Lovett, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berman, M.
Right arrow Articles by Lovett, D. H.
Submitted on May 1, 2006
Accepted on November 27, 2006

Cardiac Matrix Metalloproteinase-2 Expression Independently Induces Marked Ventricular Remodeling and Systolic Dysfunction

Marina Berman1, John Teerlink2, Luyi Li1, Rajeev Mahimkar1, Bo-Qing Zhu1, Anita Nguyen1, Sia Dahi1, Joel Karliner3, and David H. Lovett4*

1 Medicine/SFVAMC, University of California, San Francisco, San Francisco, California, United States
2 Medicine/SFVAMC, University of California, San Francisco, San Francisco, California, United States; Medicine, UCSF, United States
3 Medicine/SFVAMC, University of California, San Francisco, San Francisco, California, United States; V. A. Medical Center, Cardiology Dept. - 111-C8, San Francisco, California, United States
4 Nephrology Section (111J), V.A. Medical Center, San Francisco, California, United States

* To whom correspondence should be addressed. E-mail: david.lovett{at}med.va.gov.

Although enhanced cardiac matrix metalloproteinase-2 (MMP-2) synthesis has been associated with ventricular remodeling and failure, whether MMP-2 expression is a direct mediator of this process is unknown. We generated transgenic mice expressing active MMP-2 driven by the {alpha}-myosin heavy chain promoter. At 4 months MMP-2 transgenic hearts demonstrated expression of the MMP-2 transgene, myocyte hypertrophy, breakdown of Z-band registration, lysis of myofilaments, disruption of sarcomere and mitochondrial architecture, and cardiac fibroblast proliferation. Hearts from 8 month old transgenic mice displayed extensive myocyte disorganization and dropout with replacement fibrosis and perivascular fibrosis. Older transgenic mice also exhibited a massive increase in cardiac MMP-2 expression, representing recruitment of endogenous MMP-2 synthesis, with associated expression of MMP-9 and MT1-MMP. Increases in diastolic (C, 33 ± 3 vs. MMP, 51 ± 12 µl; p=0.003) and systolic (C, 7 ± 2 vs. MMP, 28 ± 14 µl; p=0.003) LV volumes and relatively preserved stroke volume (C, 26 ± 4 vs. MMP, 23 ± 3 µl; p=0.16) resulted in markedly decreased LV ejection fraction (C, 78 ± 7 vs. MMP, 48 ± 16%; p=0.0006). Markedly impaired systolic function in the MMP transgenic mice was demonstrated in the reduced preload adjusted maximal power (C, 240 ± 84 vs. MMP, 78 ± 49 mWatts/µl2; p=0.0003) and decreased end-systolic pressure volume relation (Eea; C, 7.5 ± 1.5 vs. MMP, 4.7 ± 2.0; p=0.016). Expression of active MMP-2 is sufficient to induce severe ventricular remodeling and systolic dysfunction in the absence of superimposed injury.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. D. Kandasamy and R. Schulz
Glycogen synthase kinase-3{beta} is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts
Cardiovasc Res, September 1, 2009; 83(4): 698 - 706.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Wang, T. Oka, F. L. Chow, S. B. Cooper, J. Odenbach, G. D. Lopaschuk, Z. Kassiri, and C. Fernandez-Patron
Tumor Necrosis Factor-{alpha}-Converting Enzyme Is a Key Regulator of Agonist-Induced Cardiac Hypertrophy and Fibrosis
Hypertension, September 1, 2009; 54(3): 575 - 582.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. D. Kandasamy, A. K. Chow, M. A.M. Ali, and R. Schulz
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix
Cardiovasc Res, August 20, 2009; (2009) cvp268v2.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
F. G. Spinale, G. P. Escobar, R. Mukherjee, J. A. Zavadzkas, S. M. Saunders, L. B. Jeffords, A. M. Leone, C. Beck, S. Bouges, and R. E. Stroud
Cardiac-Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase in Mice: Effects on Myocardial Remodeling With Aging
Circ Heart Fail, July 1, 2009; 2(4): 351 - 360.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
A. Biolo, S. Ramamurthy, L. H. Connors, C. J. O'Hara, H. K. Meier-Ewert, P. T. Soo Hoo, D. B. Sawyer, D. S. Seldin, and F. Sam
Matrix Metalloproteinases and Their Tissue Inhibitors in Cardiac Amyloidosis: Relationship to Structural, Functional Myocardial Changes and to Light Chain Amyloid Deposition
Circ Heart Fail, November 1, 2008; 1(4): 249 - 257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. T. McCloskey, S. Turcato, G.-Y. Wang, L. Turnbull, B.-Q. Zhu, T. Bambino, A. P. Nguyen, D. H. Lovett, R. A. Nissenson, J. S. Karliner, et al.
Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H205 - H212.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.